The SCL/TAL1 transcription factor represses the stress protein DDiT4/REDD1 in human hematopoietic stem/progenitor cells

Stem Cells

Volumn 33, Issue 7, 2015, Pages 2268-2279

  Benyoucef, Aissa ^a,b,c,d   Calvo, Julien ^a,b,c,d   Renou, Laurent ^a,b,c,d   Arcangeli, Marie Laure ^a,b,c,d   Van Den Heuvel, Anita ^e   Amsellem, Sophie ^f   Mehrpour, Maryam ^g   Larghero, Jerome ^h   Soler, Eric ^a,b,e   Naguibneva, Irina ^a,b,c,d   Pflumio, Francoise ^a,b,c,d  

^a DIF   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h SAINT LOUIS HOSPITAL   (France)

Author keywords

DDiT4; Hematopoietic stem cells; Maintenance self renewal; SCL TAL1

Indexed keywords

DNA DAMAGE INDUCED TRANSCRIPT 4; HEAT SHOCK PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DDIT4 PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL PEPTIDE; STIL PROTEIN, HUMAN; TAL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENE SILENCING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; GENETIC TRANSFECTION; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; STEM CELL;

MAMMALIA;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HEAT-SHOCK PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED NOD; PROTO-ONCOGENE PROTEINS; STEM CELLS; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84931572536     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2028     Document Type: Article

References (44)

1. Orkin SH, Zon LI,. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008; 132: 631-644.
2. Lecuyer E, Hoang T,. SCL: From the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 2004; 32: 11-24.
3. Mikkola HK, Klintman J, Yang H, et al., Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003; 421: 547-551.
4. Hall MA, Curtis DJ, Metcalf D, et al., The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100: 992-997.
5. Kunisato A, Chiba S, Saito T, et al., Stem cell leukemia protein directs hematopoietic stem cell fate. Blood 2004; 103: 3336-3341.
6. Curtis DJ, Hall MA, Van Stekelenburg LJ, et al., SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 2004; 103: 3342-3348.
7. Brunet de la Grange P, Zink E, Armstrong F, et al., Impairment of granulo-monocytic development of human common myeloid progenitors but not of granulo-monocytic progenitors by decreasing stem cell leukemia/T-cell acute leukemia 1 expression. Stem Cells 2008; 26: 1658-1662.
8. Brunet de la Grange P, Armstrong F, Duval V, et al., Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood 2006; 108: 2998-3004.
9. Lacombe J, Herblot S, Rojas-Sutterlin S, et al., Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 2010; 115: 792-803.
10. Reynaud D, Ravet E, Titeux M, et al., SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood 2005; 106: 2318-2328.
11. Souroullas GP, Salmon JM, Sablitzky F, et al., Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 2009; 4: 180-186.
12. Wilson NK, Miranda-Saavedra D, Kinston S, et al., The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 2009; 113: 5456-5465.
13. Wullschleger S, Loewith R, Hall MN,. TOR signaling in growth and metabolism. Cell 2006; 124: 471-484.
14. Shoshani T, Faerman A, Mett I, et al., Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283-2293.
15. Ellisen LW, Ramsayer KD, Johannessen CM, et al., REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10: 995-1005.
16. Brugarolas J, Lei K, Hurley RL, et al., Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18: 2893-2904.
17. Sofer A, Lei K, Johannessen CM, et al., Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005; 25: 5834-5845.
18. DeYoung MP, Horak P, Sofer A, et al., Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22: 239-251.
19. Yilmaz OH, Valdez R, Theisen BK, et al., Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441: 475-482.
20. Chen C, Liu Y, Liu R, et al., TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205: 2397-2408.
21. Majeti R, Park CY, Weissman IL,. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007; 1: 635-645.
22. Calvo J, BenYoucef A, Baijer J, et al., Assessment of human multi-potent hematopoietic stem/progenitor cell potential using a single in vitro screening system. PLoS One 2012; 7: e50495.
23. Ravet E, Reynaud D, Titeux M, et al., Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood 2004; 103: 3326-3335.
24. Armstrong F, Brunet de la Grange P, Gerby B, et al., NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood 2009; 113: 1730-1740.
25. Subramanian C, Opipari AW, Jr., Castle VP, et al., Histone deacetylase inhibition induces apoptosis in neuroblastoma. Cell Cycle 2005; 4: 1741-1743.
26. Kolodziej KE, Pourfarzad F, de Boer E, et al., Optimal use of tandem biotin and V5 tags in ChIP assays. BMC Mol Biol 2009; 10: 6.
27. Soler E, Andrieu-Soler C, Boer E, et al., A systems approach to analyze transcription factors in mammalian cells. Methods 2011; 53: 151-162.
28. Hobbs RM, Seandel M, Falciatori I, et al., Plzf regulates germline progenitor self-renewal by opposing mTORC1. Cell 2010; 142: 468-479.
29. Hsu HL, Wadman I, Baer R,. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci USA 1994; 91: 3181-3185.
30. Palii CG, Perez-Iratxeta C, Yao Z, et al., Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 2011; 30: 494-509.
31. Capron C, Lecluse Y, Kaushik AL, et al., The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 2006; 107: 4678-4686.
32. Gottgens B, Nastos A, Kinston S, et al., Establishing the transcriptional programme for blood: The SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J 2002; 21: 3039-3050.
33. Doulatov S, Notta F, Laurenti E, et al., Hematopoiesis: A human perspective. Cell Stem Cell 2012; 10: 120-136.
34. Krosl J, Austin P, Beslu N, et al., In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9: 1428-1432.
35. Antonchuk J, Sauvageau G, Humphries RK,. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002; 109: 39-45.
36. Auvray C, Delahaye A, Pflumio F, et al., HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica 2012; 97: 168-178.
37. Amsellem S, Pflumio F, Bardinet D, et al., Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003; 9: 1423-1427.
38. Lansdorp PM, Sutherland HJ, Eaves CJ,. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J Exp Med 1990; 172: 363-366.
39. Maiese K, Chong ZZ, Shang YC, et al., mTOR: On target for novel therapeutic strategies in the nervous system. Trends Mol Med 2013; 19: 51-60.
40. Li XH, Ha CT, Fu D, et al., REDD1 protects osteoblast cells from gamma radiation-induced premature senescence. PLoS One 2012; 7: e36604.
41. Yoshida T, Mett I, Bhunia AK, et al., Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 2010; 16: 767-773.
42. Iriuchishima H, Takubo K, Matsuoka S, et al., Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. Blood 2011; 117: 2373-2377.
43. Rohrabaugh SL, Campbell TB, Hangoc G, et al., Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cells Mol Dis 2011; 46: 318-320.
44. Anjos-Afonso F, Currie E, Palmer HG, et al., CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures. Cell Stem Cell 2013; 13: 161-174.